Ramping production of Remdesivir to meet demand: Pharma firms
The Hindu
There are seven manufacturers of Remdesivir in the country.
Several manufacturers of Remdesivir, that is being used in treatment of COVID-19, said they have ramped up production of the drug to meet its rising demand across the country. In view of increased demand for the medicine due to a spike in COVID-19 cases, the centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the situation in the country improves. A Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing Remdesivir at three of our facilities. To cater to the demand we have ramped up our production from the earlier 5-6 lakh vials a month to 10-12 lakh vials a month, which we will scale towards 20 lakh vials a month.” In a few weeks the supply situation will be a far more stable one, the company said.More Related News

After more-than-two-year wait, the flyover at Goripalayam junction will be commissioned on Saturday. As of now, the main arm of the new flyover, named after freedom fighter Netaji Subash Chandra Bose, will help to decongest vehicular movement from Tamukkam junction till Nelpettai junction on East Veli Street.












